PL Developments Builds a Smarter, Healthier Supply Chain with Kinaxis
'With Maestro, they're not just replacing spreadsheets, they're unlocking real-time visibility, rapid execution and scalable decision making."
Specializing in end-to-end solutions from product development to distribution, PLD supplies some of the largest retailers in the U.S. including Walmart, Walgreens, CVS, Costco, Sam's Club and Target with health and wellness products in categories including analgesics, cough/cold, allergy and digestive. Due to market expansion and rapidly increasing consumer demand for accessible and affordable healthcare products, PLD needed to deliver to its retail partners with greater speed, accuracy and responsiveness. With manual planning tools and siloed decision-making, PLD was challenged by limited visibility across its operations leading to delayed order confirmations and high inventory levels.
To maintain its position as a trusted industry leader, PLD needed a next-generation supply chain platform to meet evolving customer expectations while continuing to deliver on the promise of quality at every step. After rigorous evaluation, Maestro stood out for its unmatched ability to unify data and provide real-time insights, enabling predictive planning to anticipate demand. Maestro allows PLD to optimize inventory, respond faster to market shifts and scale execution across every function of the business with fewer resources and greater supply chain visibility.
'Consumers expect fast access to trusted health and wellness products, and our retail partners need the inventory to match shifting demand,' s aid Thomas Crowe, chief supply chain officer at PL Developments. 'With Maestro, we can anticipate this demand, simulate scenarios, plan for market shifts and make confident, data-driven decisions in minutes. It's a game changer that empowers our team to deliver the innovation and products consumers rely on every single day and Kinaxis is now a key part of that innovation.'
'PLD is a prime example of a forward-thinking manufacturer embracing the speed and intelligence today's healthcare supply chains demand,' said Mark Morgan, president of global commercial operations at Kinaxis. 'With Maestro, they're not just replacing spreadsheets, they're unlocking real-time visibility, rapid execution and scalable decision making. We're proud to support PLD as they deliver the trusted healthcare products consumers rely on, faster and more efficiently than ever.'
To learn more about Kinaxis and its supply chain management solutions, please visit Kinaxis.com.
About Kinaxis
Kinaxis is a global leader in modern supply chain orchestration, powering complex global supply chains and supporting the people who manage them, in service of humanity. Our powerful, AI-infused supply chain orchestration platform, Maestro™ combines proprietary technologies and techniques that provide full transparency and agility across the entire supply chain — from multi-year strategic planning to last-mile delivery. We are trusted by renowned global brands to provide the agility and predictability needed to navigate today's volatility and disruption. For more news and information, please visit kinaxis.com or follow us on LinkedIn.
Source: Kinaxis Inc
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Wire
an hour ago
- Business Wire
Paired Power Secures Patent for PairTree™ Solar-Integrated EV Charger System
CAMPBELL, Calif.--(BUSINESS WIRE)-- Paired Power, a leading manufacturer of solar-powered electric vehicle (EV) charging systems, announced the award of U.S. Patent No. 12,375,024 for its innovative PairTree™ solar canopy solution. The patent, titled 'Solar canopy systems and methods,' formally recognizes Paired Power's proprietary approach to solar canopy installation, significantly expanding the deployment speed and accessibility of electric vehicle charging in situations with limited or no grid power. This marks the company's fourth patent since 2016, reinforcing its position as the innovator in solar powered EV charging. The newly patented technology covers a unique method for raising solar panels above a foundation using an integrated lift mechanism. Unlike conventional canopy installations that require elevated work, scaffolding, or external lifts, the PairTree™ system allows panels to be safely assembled at ground level before being elevated into place. This streamlined approach reduces installation time, labor costs, and safety risks, making deployment of EV charging infrastructure faster with fewer approval bottlenecks in a wider range of environments. "Securing this patent for PairTree is a monumental achievement for Paired Power," said Tom McCalmont, CEO of Paired Power. 'It embodies our commitment to making sustainable energy solutions more accessible, efficient, and deployable for everyone, everywhere. The ability to rapidly install solar canopies with minimal effort will accelerate the adoption of electric vehicles by providing charging options in previously underserved locations." PairTree reduces installation time from weeks to hours, enabling rapid deployment with immediate functionality and minimal site disruptions. Unlike traditional EV chargers that require trenching and major construction, PairTree preserves existing parking spaces and reduces or eliminates reliance on the grid during installation. Paired Power's signature combination of solar power and energy storage allows PairTree to create its own self-powered microgrid, further enhancing the solution's utility for remote, off-grid or utility-constrained locations. By generating and storing its own energy, the system also empowers operators to avoid costly demand charges often levied by utilities during peak energy use. Its modular, flexible design enables fast, cost-effective EV charger deployment where and when it's needed most. To learn more about the PairTree™ system, visit To delve further into the company's full suite of microgrid EV charging solutions, join Paired Power on Thursday, September 18, for a live webinar at 2:00pm EDT/11:00am PDT. About Paired Power: Trusted by cities, governments, and leading corporations, Paired Power manufactures solar-powered microgrid electric vehicle charger facilities (EVCF) that enable rapid deployment of new EV infrastructure without requiring expansions of existing grid capacity. Paired Power's flagship products are PairTree™, a microgrid solar powered EV charger that pairs a 4.6kW solar array with a 42.4 kWh Battery Energy Storage System (BESS) to provide Level 2 EV charging day or night, and PairFleet™, a larger microgrid designed to serve greater numbers of vehicle charging needs and can be customized based on a client's energy requirements. For more information about Paired Power, visit
Business Wire
an hour ago
- Business Wire
SWBC Mortgage Expands Access with Down Payment Grant Program
SAN ANTONIO--(BUSINESS WIRE)--SWBC Mortgage Corporation is proud to announce the continued success of its Homeownership Expansion Loan Program (HELP™), which has already helped hundreds of families and individuals achieve the dream of homeownership. Since its launch, the program has provided more than $2.3 million in down payment assistance and supported the closing of 487 home loans across the country. This program is about making homeownership more accessible, whether it's your first home or your next. Share HELP™ is a grant program designed to reduce the upfront costs of purchasing a home. Available to both first-time and repeat homebuyers, the program offers a grant of up to 2% of the home's purchase price (up to $5,000) when the buyer contributes at least 1% toward the down payment. First-time homebuyers meeting a 50% Area Median Income (AMI) may also qualify for an additional $2,500 in assistance. Unlike a loan, the grant does not require repayment, making it a powerful tool for increasing access to homeownership. Eligibility is based on income, with assistance available to borrowers earning 80% or less of the area median income (AMI). Borrowers receive a Form 1099 for grant funds utilized. Applicants should consult a tax preparer to determine whether the funds may be taxable. 'This program is about making homeownership more accessible, whether it's your first home or your next,' said Susan Stewart, CEO of SWBC Mortgage. 'We're giving buyers a head start without burdening them with extra debt.' Program Benefits Include: Up to $5,000 in down payment assistance No repayment of assistance funds required (funds may be taxable) Available to eligible first-time and repeat buyers Backed by conventional loan financing Lower mortgage insurance (MI) compared to many other loan options Temporary buydown options available for reduced initial monthly payments No interest rate difference if the buyer uses the grant This innovative grant solution offers financial flexibility and support, helping to reduce some of the upfront challenges of home buying. For more information about the SWBC Mortgage's Homeownership Expansion Loan Program™ and to see if you qualify, please visit our website. About SWBC Mortgage Corporation SWBC Mortgage Corporation, a wholly owned subsidiary of SWBC, is a full-service mortgage lender approved by FNMA, FHLMC, and GNMA. Headquartered in San Antonio, Texas, SWBC Mortgage has been providing mortgage banking services since 1988. Through the changing landscape of the mortgage industry, the company has remained committed to service, integrity, and stability while growing to serve communities and borrowers in 44 states + D.C. Today, SWBC Mortgage is consistently recognized as one of the top 50 lenders in America and is home to numerous top-ranked originators. Building on a rich history of success, SWBC Mortgage has highly experienced team members who leverage streamlined digital tools to deliver efficient service and support, while providing a personal, experienced touch to the mortgage process. SWBC Mortgage provides innovative technology and resources built to streamline the mortgage process and provide support from application through servicing. About SWBC As a diversified financial services company, SWBC provides financial institutions, businesses, and individuals with a wide range of insurance, mortgages, wealth management, employee benefits, and more. Headquartered in San Antonio, Texas, SWBC has partners and divisions across all 50 states and Mexico and manages businesses worldwide. No matter how wide its reach, SWBC always listens to our customers' needs, analyzes their current situations, and recommends customized solutions. For more information about our innovative approach to personalized service, visit SWBC's website. SWBC Mortgage Corporation, NMLS #9741. Check licensing at AZ BK #0950067; Licensed by the Department of Financial Protection and Innovation under the California Residential Mortgage Lending Act #4130449; Licensed by the N.J. Dept. of Banking and Insurance. Massachusetts Mortgage lender & Mortgage Broker License MC9741. Loans subject to credit and property approval, restrictions and conditions may apply. Not all loan programs or loan amounts available in all areas. Programs and guidelines subject to change without notice. Corporate office: 9311 San Pedro Ave., Ste. 100, San Antonio, TX 78216. © 2025 SWBC. All rights reserved.
Business Wire
2 hours ago
- Business Wire
Seek Labs Unveils Investigational, Equipment-Free Molecular Prototype for MTB on Rapid-Deploy SeekIt™ Platform
SALT LAKE CITY--(BUSINESS WIRE)--Seek Labs, a biotech company boldly seeking a healthier world through AI-powered discovery, programmable therapeutics, and point-of-care diagnostics, today announced a significant advancement in the global fight against tuberculosis (TB) with an investigational prototype for Mycobacterium tuberculosis (MTB) detection on its SeekIt™ platform. In internal analytical testing, the MTB SeekIt test delivered accurate results in under 60 minutes. Importantly, this innovation addresses a key limitation that has historically hindered effective TB diagnostics: breaking apart MTB's waxy, lipid-rich cell wall to gain access to detectable genetic material. In internal testing, SeekIt's proprietary chemical lysis step achieved this in just 15 minutes without heat, mechanical disruption, or complex lab tools and skilled operators. Seek Labs achieved a functional investigational prototype in one quarter by leveraging its suite of in-house, pre-validated diagnostic technologies, focusing new innovation efforts on the MTB-specific lysis step. Share Seek Lab's MTB test demonstrates the speed, adaptability, and field-readiness of the modular SeekIt platform. All SeekIt's components—lysis chemistry, extraction, amplification, and detection—are proprietary to Seek Labs, exclusively discovered and developed in-house, and have been internally validated for performance and integration across multiple applications. The Global TB Testing Gap TB kills more than 1.25 million people each year, with nearly one in three cases going undiagnosed. In high-burden, resource-limited settings, centralized molecular tests face major hurdles: Pathogen complexity: MTB's waxy, lipid-rich cell wall has proven intractable to portable lysis methods for decades. Infrastructure dependence: Gold-standard molecular tests require expensive, power-intensive instruments, refrigeration, and highly skilled (or trained) operators. Sample limitations: Sputum collection is challenging for many patients and can deter testing. 'TB diagnostics have long been limited by gaps in both infrastructure and innovation that have often meant severe consequences for patient care and public health,' said Jared Bauer, CEO of Seek Labs. 'Our rapid, point-of-care SeekIt MTB test is designed to enable molecular-level detection in settings where access to equipment and electricity may be limited.' From Sample to Result: A Simplified Workflow At the core of the MTB SeekIt test is a proprietary, single-step chemical lysis buffer, involving a specially-formulated solution that disrupts MTB cells to release their genomic DNA. This breakthrough innovation takes just 15 minutes at room temperature, while competing methods (high-heat incubation or mechanical bead-beating) require longer times plus expensive equipment, specialized technicians, and complex infrastructure. More importantly, the integrated SeekIt test means the lysate itself flows seamlessly into SeekIt's downstream test components: Seek Extraction™ — A proprietary membrane-based binding system, developed and validated by Seek Labs, that rapidly captures MTB DNA without lab instruments. In validation testing, the MTB DNA yield for Seek Extraction was consistently more than 70% when compared to leading spin-column kits. Seek Amplification™ — A proprietary process that exponentially copies DNA at a constant temperature, detecting as few as 10 MTB genomic copies in 30 minutes without thermal cycling (internally validated), the conventional lab-based method. Molecular Lateral Flow Assay (mLFA) — A test strip that delivers clear, visual results in minutes indicating the presence of amplified DNA in a manner that can be optionally paired with the SeekIt mobile app for digital analysis and connectivity. Speed as a Strategy Conventional development of a molecular test for MTB can take a year or more. Seek Labs achieved a functional investigational prototype in one quarter by leveraging its suite of in-house, pre-validated diagnostic technologies, focusing new innovation efforts on the MTB-specific lysis step. This rapid-deployment approach illustrates how SeekIt can be rapidly developed for numerous high-priority diseases in record time. 'This was more than a fast project; it's proof of our platform's flexibility,' said Kim Wirthlin, Chief Strategy Officer. 'By focusing our innovation on the MTB-specific lysis step for compatibility with our downstream isothermal amplification, we solved one of TB diagnostics' toughest technical challenges and produced a functional investigational prototype in a single quarter.' From Conference to Collaboration Seek Labs will debut the MTB SeekIt prototype at the 2025 Next Generation Dx Conference (August 18–20, 2025, Washington, D.C.), including: Podium Presentation — Enabling Point of Care Diagnostics Track, Tuesday, August 19 at 10:00 AM ET. Scientific Poster — Detailing the proprietary lysis chemistry, rapid development process, and validation data. Seek Labs is actively seeking partners across global health (ministries of health, TB-focused NGOs, and diagnostics distributors in high-burden regions such as sub-Saharan Africa and Southeast Asia) to advance the MTB SeekIt test through clinical validation, regulatory approval, and deployment. 'Innovation means nothing if it doesn't reach people,' said Bauer. 'We want to work with those who share our vision to advance development of accurate, accessible TB testing solutions wherever they're needed most.' About Seek Labs At Seek Labs, we don't wait for change—we build it. We're pursuing the breakthroughs the world can't wait for by developing programmable 'seek-and-destroy' therapeutics and point-of-care molecular diagnostics that close the gap between outbreak and intervention. At the core of this mission is a layered architecture: BioSeeker™ serves as the Intelligence Layer, continuously mapping conserved viral vulnerabilities in real time; these insights activate our Deployment Layers (PTAP™ for programmable therapeutics and SeekIt™ for molecular diagnostics), forming a full-stack development engine designed to accelerate response, innovation, and impact across global health. Headquartered in Salt Lake City, Seek Labs is a proud member of BioHive, Utah's collaborative life sciences ecosystem. Together with our partners, we're building faster, smarter solutions for the world's most urgent health challenges. Forward-Looking Statements and Regulatory Disclaimer This press release contains forward-looking statements, including statements regarding development timelines, clinical validation, regulatory pathways, and potential collaborations. Forward-looking statements are based on current expectations and assumptions and are subject to risks and uncertainties—including scientific, regulatory, manufacturing, clinical, and commercial risks—that could cause actual results to differ materially. The MTB SeekIt assay is an investigational device. Limited by Federal law to investigational use.
